Clinical Trial Update: A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 trial updating safety and immunogenicity of SII Yellow Fever Vaccine in healthy infants compared with STAMARIL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• SII Yellow Fever Vaccine (Yellow fever vaccine)
• Stamaril (Yellow fever vaccine (live attenuated))

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Yellow Fever | Phase 3 | Status: UNKNOWN